Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
34
NCT05757856
A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 20, 2023
Completion: May 22, 2025